STOCKS TELEGRAPH

Tag: NanoVibronix Inc.

  • Surge In NanoVibronix (NAOV) Shares Sparks Market Curiosity

    Surge In NanoVibronix (NAOV) Shares Sparks Market Curiosity

    The stock market is seeing a spectacular surge in NanoVibronix, Inc. (NASDAQ: NAOV) shares, which were rising 381.88% to $14.17 as of the most recent check today. The spike seems to be driven by recent encouraging developments about NanoVibronix’s core medical product, UroShield, and its expansion of distribution in Australia, even if there was no immediate breaking news.

    Extended and Renewing Contract

    NanoVibronix announced earlier this month that it has extended and renewed its exclusive three-year distribution arrangement with Dukehill Healthcare Pty Ltd, a Queensland-based company. All Australian states are now covered by Dukehill’s distribution rights, which were formerly restricted to Queensland and New South Wales.

    This move comes after a noticeable rise in orders and questions from medical facilities, especially in Victoria and South Australia, indicating increased interest in UroShield’s potential in clinical settings.

    Increasing Trust in UroShield’s Performance

    The enlarged agreement follows an independent research that demonstrated UroShield’s efficacy in reducing catheter-associated problems and enhancing patient outcomes. The market’s favorable reaction is probably due in part to the research, which has reaffirmed NanoVibronix’s dedication to extending access to its technology.

    NAOV stressed that more patients and healthcare professionals around Australia would be able to take use of UroShield’s cutting-edge catheter care capabilities thanks to this renewed cooperation.

    Upcoming National Exposure and Clinical Engagement

    Dukehill will introduce UroShield at the 33rd National Conference on Incontinence, hosted by Continence Health Australia in Hobart in May 2025, in an effort to increase awareness and uptake even more. Clinicians from all around the nation will come together for the event, which will provide them a forum to talk about the study’s results and interact with the technology.

    The meeting is seen by NanoVibronix as a crucial chance to highlight UroShield’s therapeutic benefits and bolster its market share in Australia. NAOV seems to be well-positioned for further expansion in the healthcare technology industry due to its growing clinical relationships and growing worldwide awareness.

  • NanoVibronix (NAOV) Stock Surges In Pre-Market Trading Following A Positive Study

    NanoVibronix (NAOV) Stock Surges In Pre-Market Trading Following A Positive Study

    The share price of NanoVibronix, Inc. (NASDAQ: NAOV) increased significantly during pre-market trading, going up 79.82% to $3.92 as of the last check. The notable increase follows the publication of a successful independent study evaluating the company’s primary medical product, UroShield, by the Australian and New Zealand Continence Journal.

    An independent Validates UroShield’s Effectiveness

    The study highlights the device’s efficacy in reducing catheter-associated urinary tract infections (CAUTIs) and its potential for widespread clinical use among patients with indwelling urinary catheters (IUCs). UroShield customers showed encouraging outcomes from the independent health service research showing that Catheter blockages reduced by 70% while Catheter changes decreased by 52.3%.

    The positive impact of the device on patient care is further supported by the fact that clinicians saw less catheter-related interventions and more patient comfort. The study also discovered that UroShield decreased nursing effort and produced measurable cost savings for medical professionals.

    Better Patient Results and Cost Effectiveness

    The effectiveness of UroShield in a New Zealand District Nursing Service was described in depth in the published study, which also highlighted how it improves the quality of life for patients with IUCs. UroShield dramatically decreased catheter-associated infections and obstructions, resulting in fewer medical interventions and improved patient comfort, according to the Quality Improvement initiative.

    Furthermore, during a five-month period, the final cost analysis showed a 63.5% drop in resource consumption, mostly as a result of fewer medical interventions and emergency call-outs.

    Devices of the Future in Development

    Along with the encouraging trial findings, NanoVibronix recently reported that the design process for its next PainShield and UroShield devices was finished. In December 2024, a third-party contractor completed the creation of the prototype with an emphasis on lowering assembly costs, minimizing risk factors, and improving user ease.

    These advancements show NanoVibronix’s continuous efforts towards innovation in medical technology and supporting its prospects for further market expansion and acceptance. With these developments, NAOV is securing its position in the healthcare sector by offering innovative solutions to improve patient care and operational efficacy.

  • Upcoming Presentation: NanoVibronix Inc. (NAOV) stock Rallies After Hours

    On January 07, NanoVibronix Inc. (NAOV) announced its presentation at the upcoming H.C. Wainwright BioConnect Virtual Conference. Consequently, the stock became bullish in the after-hours on Friday.

    During the regular session, NAOV stock traded in the red with a loss of 3.88% at its close of $0.99. Following the announcement, the stock gained 6.06% to reach $1.05 in the after hours.

    The noninvasive biological response-activating devices developer, NanoVibronix Inc. was founded in 2003. Currently, its 27.95 million outstanding shares trade at a market capitalization of $27.67 million.

    H.C. Wainwright BioConnect Conference

    As per Friday’s announcement, NAOV’s Chief Executive Officer will present at the conference. Furthermore, the H.C. Wainwright BioConnect Virtual Conference will take place from January 10 to January 13, 2022.

    Mr. Murphy will provide updates on the company’s business during the presentation.

    NAOV’s VA Distribution Network Expansion

    On January 06, the company announced the expansion of its VA distribution network. Delta Medical, LLC has been added to the distribution network in order to increase the sale of NAOV’s PainShield products to Veteran’s Administration hospitals and healthcare facilities.

    Further, it is owned by Justin A. Brooks, who has vast experience in medical devices and deep-rooted relationships within the VA system.

    Previously, the company had sighed a distribution agreement with Applied Medical Solutions, LLC. Applied Medical serves as the distributor of NAOV’s PainShield products to Veteran Administration facilities throughout the U.S. Added to that, now Delta Medical will be the sub-distributor of the products for expanding its access.

    PainShieldTM

    PainShield is NOAV’s ultrasound device that delivers a localized ultrasound effect for treating pain and inducing soft tissue healing at a targeted area. Moreover, PainShield can be used in any kind of setting, be it home or work or a clinical setting. It has been shown to effectively treat chronic and acute pains without any risk of abuse as is the case with most opioid-based pain treatments.

    NAOV’s Financial Results

    On November 16, the company announced its third-quarter financial results of 2021.

    According to the results, NOAV has revenue of $499,000 in the third quarter of 2021. Comparatively, the revenue was $150,000 in Q3 of 2020. This shows a humungous increase of 233% year over year.

    In addition, the company incurred a net loss of $6.7 million in the third quarter of 2021, against $922,000 in the year-ago period. Resultantly, the net loss per basic and diluted share was $0.26 and $0.10 in the third quarter of 2021 and 2020, respectively.

  • NanoVibronix Inc. (NAOV) stock rises in after-hour trading. Why is it so?

    NanoVibronix Inc. (NAOV) stock rises in after-hour trading. Why is it so?

    NanoVibronix Inc. (NAOV) stock rises by 7.84% in the after-hour trading session while there is no recent news available related to this gain in NAOV stock price. NanoVibronix is a medical device company specializing in the development of medical devices based on its innovative low intensity surface acoustic wave technology. This technology enables the development of low-frequency ultrasound waves for a range of medical applications, including the disruption of biofilms and bacteria invasion, as well as pain management.

    Recent Important Events

    On March 31, NAOV stock announced their Special Meeting of Stockholders, which was scheduled for March 31, 2021, that it has got postponed in order to give stockholders more time to vote. The meeting is set to take place again on April 14, 2021. NAOV would continue to receive proxies from its stockholders for the resolutions set out in the Company’s proxy statement throughout the time of postponement. Until properly repealed, proxies previously submitted in relation to the Special Meeting will be voted on at the reconvened meeting. All stockholders who have not yet voted are encouraged to do so before April 13, 2021.

    Also on March 2, 2021, NAOV revealed that through a service disabled veteran group, NAOV’s UroShield urology therapy device has been added to the Federal Supply Schedule, making it possible for Veterans being handled by the Veterans Administration to obtain and use the UroShield.

    The PainShield, NanoVibronix’s other patented product, was put on the Federal Supply Schedule on September 1, 2019, ensuring veterans’ access to non-opioid pain treatment. Veterans who have indwelling Foley catheters will now get UroShield which is a medication to prevent Catheter-Associated Urinary Tract Infections.

    Conclusion

    The postponement of Special Meeting of Stockholders could be the possible reason for this change in NAOV stock price since the meeting has yet to happen. Until the meeting takes place, we will probably witness the NAOV stock to vary quite a few time. The investors would also be looking forward to the final result of this meeting.

  • 35 stocks making the biggest moves premarket today

    35 stocks making the biggest moves premarket today

    FuelCell Energy Inc. (FCEL) stock soared 4.75% to $10.15 in the pre-market trading. The most recent rating by JP Morgan, on November 19, 2020, is a Neutral.

    SCWorx Corp. (NASDAQ: WORX) shares are trading down -6.76% at $2.07 at the time of writing. Company’s 52-week ranged between $1.00 to $14.88.

    Nano Dimension Ltd. (NNDM) lost over -12.1% at $5.74 in pre-market trading Monday, November 30, 2020, after announcing that it has entered into definitive agreements with investors for the sale of 11,960,160 of the Company’s American Depositary Shares (“ADSs”) at a price of $5.00 per ADS pursuant to a registered direct offering.

    Moderna Inc. (MRNA) is up more than 9.38% at $138.95 in pre-market hours on Monday, November 30, 2020 after the firm today announced that the primary efficacy analysis of the Phase 3 study of mRNA-1273 conducted on 196 cases confirms the high efficacy observed at the first interim analysis. The data analysis indicates a vaccine efficacy of 94.1%. The stock had jumped over 16.35% to $127.03 in the last trading session.

    FreightCar America Inc. (NASDAQ: RAIL) shares are trading down -3.99% at $2.65 at the time of writing. Company’s 52-week ranged between $0.73 to $2.87. Analysts have a consensus price target of $4.50.

    Blink Charging Co. (BLNK), a Specialty Retail company, dropped about -3.25% at $27.09 in pre-market trading Monday. The firm recently declared that it has acquired the EV charging operator U-Go Stations, Inc. and its portfolio of 44 DCFC charging locations.

    Zomedica Corp. (ZOM), a Drug Manufacturers – Specialty & Generic company, dropped about -1.12% at $0.1324 in pre-market trading Monday.

    GameStop Corp. (GME) is up more than 4.1% at $16.74 in pre-market hours Monday November 30, 2020 after declaring 2020 cyber week deals. The stock had jumped over 9.02% to $16.08 in the last trading session. GameStop Announces 2020 Cyber Week Deals.

    Riot Blockchain Inc. (RIOT) grew over 8.64% at $6.79 in pre-market trading today.

    Verastem Inc. (VSTM) stock moved up 5.03 percent to $2.09 in the pre-market trading after reporting the initiation of a Phase 2 registration-directed clinical trial of VS-6766, its RAF/MEK inhibitor, and defactinib, its FAK inhibitor, in patients with recurrent low-grade serous ovarian cancer (LGSOC).

    Tuniu Corporation (TOUR) gained over 6.58% at $3.4 in pre-market trading on Monday, November 30, 2020. Before the trading started on November 30, 2020.

    Novavax Inc. (NVAX) is down -8.31% to reach $115.25 after providing an update on its COVID-19 vaccine program. NVX‑CoV2373 is a stable, prefusion protein antigen derived from the genetic sequence of the SARS-CoV-2 coronavirus spike (S) protein and adjuvanted with Novavax’ proprietary Matrix‑M™. It has been trading in a 52-week range of $3.65 to $189.40.

    Occidental Petroleum Corporation (NYSE: OXY) shares are trading down -2.36% at $16.17 at the time of writing. Company’s 52-week ranged between $8.52 to $47.58. Analysts have a consensus price target of $18.

    RMG Acquisition Corp. (RMG) stock soared 6.6% to $18.1 in the pre-market trading. The firm recently revealed that the close of business on Tuesday, December 1, 2020, has been set as the record date for the determination of stockholders eligible to receive the proxy and vote at the special meeting to be held to consider and approve the previously announced merger with Romeo Systems, Inc., a Delaware corporation.

    Uxin Limited (UXIN) stock soared 2.53% to $1.62 in the pre-market trading. The most recent rating by JP Morgan, on October 23, 2019, is a Neutral.

    ReneSola Ltd (NYSE: SOL) shares are trading up 8.02% at $8.08 at the time of writing. The technology company recently announced the closing of the sale of a portfolio of operating projects located in the United Kingdom to Atmosclear Investments Ltd, an European renewable energy and cleantech private equity group. Company’s 52-week ranged between $0.85 to $5.67. Analysts have a consensus price target of $22.

    Kandi Technologies Group Inc. (KNDI) tumbled over -2.28% at $13.31 in pre-market trading today after CBAK Energy and Kandi Group signed a supply framework agreement.

    Vaxart Inc. (VXRT) is up more than 4.84% at $7.37 in pre-market hours on Monday, November 30, 2020. The stock had jumped over 9.84% to $7.03 in the last trading session. Before the trading started on November 30, 2020.

    Alibaba Group Holding Limited (BABA) is down -2.3% to reach $270.13. The internet retail company has been named a leader in Gartner’s 2020 Magic Quadrant for Cloud Database Management Systems. It has been trading in a 52-week range of $169.95 to $319.32.

    EyePoint Pharmaceuticals Inc. (EYPT) stock soared 1.97% to $0.55 in the pre-market trading. The most recent rating by B. Riley FBR, on April 06, 2020, is a Neutral.

    Canaan Inc. (NASDAQ: CAN) shares are trading down -7.83% at $5.3 at the time of writing after releasing its unaudited financial results for the three months ended September 30, 2020. Company’s 52-week ranged between $1.76 to $8.69.

    Heat Biologics Inc. (NASDAQ: HTBX) shares are trading down -0.88% at $1.13 at the time of writing. Company’s 52-week ranged between $0.19 to $4.30. Analysts have a consensus price target of $4.

    Yunji Inc. (YJ), an Internet Retail company, dropped about -7.35% at $3.53 in pre-market trading Monday. The firm recently declared its unaudited financial results for the third quarter ended September 30, 2020.

    India Globalization Capital Inc. (IGC) gained over 22.63% at $2.33 in pre-market trading Monday November 30, 2020.

    Oramed Pharmaceuticals Inc. (ORMP) stock moved up 38.65 percent to $6.17 in the pre-market trading. The healthcare firm recently reported that it has screened the first patients in its global Phase 3 trials of its oral insulin capsule ORMD-0801 for the treatment of type 2 diabetes (T2D). Before the trading started on November 30, 2020.

    Schlumberger Limited (SLB) is down -2.06% to reach $21.43. It has been trading in a 52-week range of $11.87 to $41.14.

    Ocugen Inc. (OCGN) stock plunged -1.71% to $0.294 in the pre-market trading. The firm recently revealed that Dr. Shankar Musunuri, Chairman, CEO, and Co-Founder of Ocugen, will speak on “The Promise of Cell & Gene Therapies: Regulatory and Reimbursement Roadblocks” at Xconomy’s Xcelerating Life Sciences New York & Philadelphia Virtual Event on December 3 at 10:30 a.m. Before the trading started on November 30, 2020.

    Gold Fields Limited (GFI) is down -2.52% to reach $8.5. It has been trading in a 52-week range of $3.79 to $14.90. Before the trading started on November 30, 2020.

    Marathon Patent Group Inc. (MARA) is up 15.65% to reach $4.95. It has been trading in a 52-week range of $0.35 to $6.05.

    Kingsoft Cloud Holdings Limited (KC) stock soared 5.13% to $43.69 in the pre-market trading after reporting that it will be included in the MSCI China Index, effective after the U.S. market close on November 30, 2020. The most recent rating by Goldman, on June 29, 2020, is a Buy.

    NanoVibronix Inc. (NASDAQ: NAOV) shares are trading up 5.26% at $0.8 at the time of writing. Company’s 52-week ranged between $0.54 to $3.50.

    Waitr Holdings Inc. (WTRH) stock moved down -1.46 percent to $3.38 in the pre-market trading.

    Hennessy Capital Acquisition Corp. IV (HCAC) gained over 9.0% at $13.69 in pre-market trading on Monday, November 30, 2020.

    Trevena Inc. (TRVN) stock plunged -4.67% to $2.45 in the pre-market trading. The most recent rating by Guggenheim, on September 14, 2020, is a Buy.

    Suncor Energy Inc. (NYSE: SU) shares are trading down -0.58% at $17.15 at the time of writing. The firm lately publicized that it, together with the other Syncrude joint venture owners – Imperial Oil Resources Limited, CNOOC Oil Sands Canada, and Sinopec Oil Sands Partnership – have agreed in principle for Suncor to become the operator of the Syncrude project by the end of 2021. Company’s 52-week ranged between $9.60 to $34.56.